The DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.
Genetic mutations and mechanisms in dilated cardiomyopathy
Open accessAbstract
Genetic mutations account for a significant percentage of cardiomyopathies, which are a leading cause of congestive heart failure.In hypertrophic cardiomyopathy (HCM), cardiac output is limited by the thickened myocardium through impaired filling and outflow.Mutations in the genes encoding the thick filament components myosin heavy chain and myosin binding protein C (MYH7 and MYBPC3) together explain 75% of inherited HCMs, leading to the observation that HCM is a disease of the sarcomere.Many mutations are "private" or rare variants, often unique to families.In contrast, dilated cardiomyopathy (DCM) is far more genetically heterogeneous, with mutations in genes encoding cytoskeletal, nucleoskeletal, mitochondrial, and calcium-handling proteins.DCM is characterized by enlarged ventricular dimensions and impaired systolic and diastolic function.Private mutations account for most DCMs, with few hotspots or recurring mutations.More than 50 single genes are linked to inherited DCM, including many genes that also link to HCM.Relatively few clinical clues guide the diagnosis of inherited DCM, but emerging evidence supports the use of genetic testing to identify those patients at risk for faster disease progression, congestive heart failure, and arrhythmia. Cardiomyopathy: diagnosis and prevalenceCardiomyopathy is defined by a pathologically abnormal myocardium.There are four major classifications of cardiomyopathy: dilated (DCM), hypertrophic (HCM), restrictive (RCM), and arrhythmogenic RV (ARVC).Cardiomyopathy is most commonly diagnosed through in vivo imaging, with either echocardiography or, increasingly, cardiac MRI.DCM refers to enlargement of the heart, which often affects all four chambers, especially late in the disease.Most commonly, DCM is associated with reduced LV function or systolic function, although early in the disease the LV may be dilated, with only minimally reduced function.In contrast, HCM is characterized by increased LV wall thickness, often targeting the septum that separates the LV from the RV (Figure 1).RCM is the most elusive, in part because the heart may appear morphologically close to normal, with only minor increased wall thickness or modestly decreased LV ejection fraction.The infiltrative process underlying RCM is often not readily detectable in vivo with even the most sensitive imaging technique.RCM is characterized by impaired filling of the heart, known as diastolic dysfunction, which reduces cardiac output.ARVC is characterized by reduced function and thinning of the RV with a fibrofatty infiltration that can be seen on MRI.Myocardial ischemia remains a common cause of DCM, accounting for approximately half of DCM.Toxic, metabolic, and immunologic causes have each been linked to DCM, as well as hypertension and valvular disease.Genetic cardiomyopathy, which runs in families, is now more commonly diagnosed, largely because surveillance for and awareness of the condition have improved.It is also now increasingly understood that more than one etiology may contribute to DCM within a given individual.Unlike cardiomyopathy that results from some of the other causes, genetic cardiomyopathy is a progressive disease.The time course is highly dependent on the age of presentation, which relates to
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hypertrophic Cardiomyopathy: A Systematic Review
Maron, B. J. (2002) · JAMA · doi:10.1001/jama.287.10.1308 · Cited by 2,224 · cited 1×
“For HCM, previous estimates were similar to DCM, but newer modalities and heightened diagnostic awareness now estimate the prevalence of HCM to be 1 in 500 (3).”
Truncations of titin causing dilated cardiomyopathy
Herman, D. S., Lam, L., Taylor, M. R. G., Wang, L., Teekakirikul, P., Christodoulou, D., Conner, L., DePalma, S. R., McDonough, B., Sparks, E., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1110186 · Cited by 1,485
Lamin A/C deficiency causes defective nuclear mechanics and mechanotransduction
Lammerding, J., Schulze, P. C., Takahashi, T., Kozlov, S. V., Sullivan, T. L., Kamm, R. D., Stewart, C. L., & Lee, R. T. (2004) · Journal of Clinical Investigation · doi:10.1172/jci19670 · Cited by 1,064
Transforming growth factor (TGF)-β signaling in cardiac remodeling
Dobaczewski, M., Chen, W., & Frangogiannis, N. G. (2011) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2010.10.033 · Cited by 934
Knöll, R., Hoshijima, M., Hoffman, H. M., Person, V., Lorenzen-Schmidt, I., Bang, M.-L., Hayashi, T., Shiga, N., Yasukawa, H., Schaper, W., et al. (2002) · Cell · doi:10.1016/s0092-8674(02)01226-6 · Cited by 786
Mutations in Sarcomere Protein Genes as a Cause of Dilated Cardiomyopathy
Kamisago, M., Sharma, S. D., DePalma, S. R., Solomon, S., Sharma, P., McDonough, B., Smoot, L., Mullen, M. P., Woolf, P. K., Wigle, E. D., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200012073432304 · Cited by 720
Myocardial Fibrosis as an Early Manifestation of Hypertrophic Cardiomyopathy
Ho, C. Y., López, B., Coelho-Filho, O. R., Lakdawala, N. K., Cirino, A. L., Jarolim, P., Kwong, R., González, A., Colan, S. D., Seidman, J. G., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1002659 · Cited by 696
Codd, M. B., Sugrue, D. D., Gersh, B. J., & Melton, L. J. (1989) · Circulation · doi:10.1161/01.cir.80.3.564 · Cited by 640
Mutations of TTN, encoding the giant muscle filament titin, cause familial dilated cardiomyopathy
Gerull, B., Gramlich, M., Atherton, J., McNabb, M., Trombitás, K., Sasse-Klaassen, S., Seidman, J. G., Seidman, C., Granzier, H., Labeit, S., et al. (2002) · Nature Genetics · doi:10.1038/ng815 · Cited by 616
Zhang, Q., Bethmann, C., Worth, N. F., Davies, J. D., Wasner, C., Feuer, A., Ragnauth, C. D., Yi, Q., Mellad, J. A., Warren, D. T., et al. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm238 · Cited by 539
Cited by
McDonagh, T. A., Metra, M., Adamo, M., Gardner, R. S., Baumbach, A., Böhm, M., Burri, H., Butler, J., Čelutkienė, J., Chioncel, O., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab670 · Cited by 19,442
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
Ponikowski, P., Voors, A. A., Anker, S. D., Bueno, H., Cleland, J. G. F., Coats, A. J. S., Falk, V., González-Juanatey, J. R., Harjola, V.-P., Jankowska, E. A., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw128 · Cited by 11,429
2016 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure
Ponikowski, P., Voors, A. A., Anker, S. D., Bueno, H., Cleland, J. G. F., Coats, A. J. S., Falk, V., González-Juanatey, J. R., Harjola, V.-P., Jankowska, E. A., et al. (2016) · European Journal of Heart Failure · doi:10.1002/ejhf.592 · Cited by 5,866
Dilated Cardiomyopathy: Genetic Determinants and Mechanisms
McNally, E. M., & Mestroni, L. (2017) · Circulation Research · doi:10.1161/circresaha.116.309396 · Cited by 786
“DCM Genetics The majority of genetic DCM is inherited in an autosomal dominant pattern with variable expressivity and penetrance (Figure 4) although specific forms of autosomal recessive, X-linked recessive, and mitochondrial inheritance each occur.(14,19,60) De novo mutations also contribute to genetic cardiomyopathy…”
Self-citationPathological Ventricular Remodeling: Mechanisms: Part 1 of 2
Burchfield, J. S., Xie, M., & Hill, J. A. (2013) · Circulation · doi:10.1161/circulationaha.113.001878 · Cited by 766
Walsh, R., Thomson, K. L., Ware, J. S., Funke, B. H., Woodley, J., McGuire, K. J., Mazzarotto, F., Blair, E., Seller, A., Taylor, J. C., et al. (2017) · Genetics in Medicine · doi:10.1038/gim.2016.90 · Cited by 734
Schultheiss, H.-P., Fairweather, D., Caforio, A. L. P., Escher, F., Hershberger, R. E., Lipshultz, S. E., Liu, P. P., Matsumori, A., Mazzanti, A., McMurray, J., et al. (2019) · Nature Reviews Disease Primers · doi:10.1038/s41572-019-0084-1 · Cited by 720
Weintraub, R. G., Semsarian, C., & Macdonald, P. (2017) · The Lancet · doi:10.1016/s0140-6736(16)31713-5 · Cited by 649
Atlas of the clinical genetics of human dilated cardiomyopathy
Haas, J., Frese, K. S., Peil, B., Kloos, W., Keller, A., Nietsch, R., Feng, Z., Müller, S., Kayvanpour, E., Vogel, B., et al. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehu301 · Cited by 557
Roberts, A. M., Ware, J. S., Herman, D. S., Schafer, S., Baksi, J., Bick, A. G., Buchan, R. J., Walsh, R., John, S., Wilkinson, S., et al. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.3010134 · Cited by 491
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
Ponikowski, P., Voors, A. A., Anker, S. D., Bueno, H., Cleland, J. G. F., Coats, A. J. S., Falk, V., González-Juanatey, J. R., Harjola, V.-P., Jankowska, E. A., et al. (2016) · Kardiologia Polska · doi:10.5603/kp.2016.0141 · Cited by 444
Clinical and Mechanistic Insights Into the Genetics of Cardiomyopathy
Burke, M. A., Cook, S. A., Seidman, J. G., & Seidman, C. E. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.08.079 · Cited by 325
Genetic Risk of Arrhythmic Phenotypes in Patients With Dilated Cardiomyopathy
Gigli, M., Merlo, M., Graw, S. L., Barbati, G., Rowland, T. J., Slavov, D. B., Stolfo, D., Haywood, M. E., Dal Ferro, M., Altinier, A., et al. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.06.072 · Cited by 315
Systems biology in cardiovascular disease: a multiomics approach
Joshi, A., Rienks, M., Theofilatos, K., & Mayr, M. (2021) · Nature Reviews Cardiology · doi:10.1038/s41569-020-00477-1 · Cited by 301
Spudich, J. A. (2014) · Biophysical Journal · doi:10.1016/j.bpj.2014.02.011 · Cited by 269
Advances in the Genetic Basis and Pathogenesis of Sarcomere Cardiomyopathies
Yotti, R., Seidman, C. E., & Seidman, J. G. (2019) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev-genom-083118-015306 · Cited by 168
Sex and gender differences in myocarditis and dilated cardiomyopathy: An update
Fairweather, D., Beetler, D. J., Musigk, N., Heidecker, B., Lyle, M. A., Cooper, L. T., & Bruno, K. A. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1129348 · Cited by 124
Targeting the sarcomere to correct muscle function
Hwang, P. M., & Sykes, B. D. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4554 · Cited by 114
Kanamori, H., Naruse, G., Yoshida, A., Minatoguchi, S., Watanabe, T., Kawaguchi, T., Yamada, Y., Mikami, A., Kawasaki, M., Takemura, G., et al. (2019) · Circulation: Heart Failure · doi:10.1161/circheartfailure.118.005418 · Cited by 84
Genetics and Genomics of Single-Gene Cardiovascular Diseases
Marian, A. J., van Rooij, E., & Roberts, R. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.09.968 · Cited by 48
“Mutations in sarcomere proteins, particularly those in the thin filaments, reduce calcium sensitivity of the myofilaments, those in actin and cytoskeletal proteins affect force transmission, and those in thick filaments affect ATPase activity (94,118).”
BackgroundDilated Cardiomyopathy: From Genetics to Clinical Management
(2019) · doi:10.1007/978-3-030-13864-6 · Cited by 32
Metadata
- Authors
- McNally, E. M., Golbus, J. R., & Puckelwartz, M. J.
- Venue
- Journal of Clinical Investigation
- Published
- 2013-01-02
- Volume
- 123
- Issue
- 1
- Pages
- 19-26
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2011112539
- Cited by
- 478
- References
- 61
- FWCI
- 30.93
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.